Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Goldmann-Favre maculopathy.

Y G Nasr1, G M Cherfan, R G Michels

  • 1El-Maghraby Specialist Hospital, Jeddah, Saudi Arabia.

Retina (Philadelphia, Pa.)
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical classification of age-related macular degeneration.

Ophthalmology·2013
Same author

Report of a Committee on a National Home for Lepers in the United States.

Public health papers and reports·2009
Same author

The Leper Home of Louisiana.

Public health papers and reports·2009
Same author

Bilateral diffuse uveal melanocytic proliferation in patients with occult carcinoma. 1990.

Retina (Philadelphia, Pa.)·2004
Same author

An unusual cause of abdominal pain.

Postgraduate medical journal·2003
Same author

Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.

Ophthalmology·2003
Same journal

Persistent placoid maculopathy: long term outcomes and prognostic factors.

Retina (Philadelphia, Pa.)·2026
Same journal

ANTI-VEGF THERAPY SWITCHING RETINAL DISEASES: Characterizing Clinical Manifestations and Common Involved Genes: ERRATUM.

Retina (Philadelphia, Pa.)·2026
Same journal

THE EFFICACY AND SAFETY OF SUBRETINAL BALANCED SALT SOLUTION INJECTION IN DIABETIC MACULAR EDEMA WITH HARD EXUDATES: ERRATUM.

Retina (Philadelphia, Pa.)·2026
Same journal

EVALUATING CLINICAL OUTCOMES OF AMNIOTIC MEMBRANE COVERAGE COMBINED WITH EARLY VITRECTOMY IN THE MANAGEMENT OF PERFORATING GLOBE INJURIES.

Retina (Philadelphia, Pa.)·2026
Same journal

Mid-Phase Hyperfluorescent Plaques as a biomarker of disease activity in Central Serous Chorioretinopathy: Clinical Course and Treatment Response - MICRoN report number Ten.

Retina (Philadelphia, Pa.)·2026
Same journal

Severe retinal non-perfusion is associated with fewer retinal lesions on ultra-wide field fundus photography in proliferative diabetic retinopathy.

Retina (Philadelphia, Pa.)·2026
See all related articles

Goldmann-Favre syndrome, a rare genetic eye disorder, was diagnosed in a teenage girl with vision loss and night blindness. Genetic counseling is recommended due to the autosomal recessive inheritance pattern observed in her family.

Area of Science:

  • Ophthalmology
  • Medical Genetics

Background:

  • Goldmann-Favre syndrome is a rare, inherited vitreoretinal degeneration.
  • It is characterized by progressive vision loss, night blindness, and specific fundus abnormalities.

Observation:

  • A 17-year-old female presented with reduced visual acuity and nyctalopia (night blindness).
  • Her parents were consanguineous (first cousins), suggesting a potential genetic link.
  • Ophthalmoscopic examination revealed characteristic maculopathy with a stellate pattern and retinoschisis.

Findings:

  • The patient exhibited classic clinical and fundus findings consistent with Goldmann-Favre syndrome.
  • Electroretinogram (ERG) abnormalities further supported the diagnosis.
  • The combination of symptoms, family history, and funduscopic findings allowed for a definitive diagnosis.

Related Experiment Videos

Implications:

  • Early diagnosis of Goldmann-Favre syndrome is crucial for management and genetic counseling.
  • Understanding the genetic basis and inheritance patterns aids in predicting disease progression.
  • Further research into the molecular mechanisms of this condition may lead to targeted therapies.